Press Releases

SAN FRANCISCO, Oct. 15, 2019 /PRNewswire/ -- Castlight Health, Inc. (NYSE: CSLT) will release its third quarter 2019 financial results on Thursday, October 24, 2019, after the market close. At 5:00 p.m. Eastern Time (ET), senior management will host a conference call to review the Company's financial performance

NEW YORK, Oct. 15, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today reported top-line data from REL-1017-202, a double-blind, placebo-controlled Phase 2 clinical study evaluating the safety, tolerability and efficacy of two doses of REL-101

MEMPHIS, Tenn., Oct. 15, 2019 /PRNewswire/ -- The world of music streaming now has a new voice: St. Jude Children's Research Hospital®. As an official Ap

PHILADELPHIA, Oct. 15, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "the Company") today announced that the Nasdaq Hearings Panel has agreed to the transfer of the Company's shares to the Nasdaq Capital Market effective at the open of business on October 15, 2019 and granted the Company until Februar

NEW YORK, Oct. 15, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that Robb Knie, Chief Exe

PHILADELPHIA, Oct. 15, 2019 /PRNewswire/ -- TMRW, the creator of the first automated robotic cryo-specimen management system designed specifically for in vitro fertilization (IVF), today presented its initial validation study for automated cryo-storage and inventory management of patient specimens at the American Society for Reproductive Medicine's Scientific Congress an

WEST LAFAYETTE, Ind., Oct. 15, 2019 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted imaging agents to improve cancer surgery, today announced that its lead molecule, OTL38, was shown to be safe and efficacious in a Phase 2 study. In this study surgeons were able to detect additional lesions in 48.3% o

CRANFORD, N.J., Oct. 15, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the MicroCap Rodeo on Oct 16th at 9:45-10:15

CAMBRIDGE, Mass., Oct. 15, 2019 /PRNewswire/ -- Vigeo Therapeutics, a clinical-stage biopharmaceutical company developing novel therapeutics to reprogram the tumor immune microenviro

SANTA BARBARA, California, Oct. 15, 2019 /PRNewswire/ -- Yardi® Claims Manager is the newest addition to the Yardi® Senior Living Suite. It helps staff at senior living communities better manage reimbursements for care provided to Medicaid recipients.